Stay updated on DS-1062a in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the DS-1062a in Lung Cancer Clinical Trial page.

Latest updates to the DS-1062a in Lung Cancer Clinical Trial page
- Check5 days agoChange DetectedA new publication citation for a pooled analysis of Datopotamab Deruxtecan in EGFR-mutated NSCLC was added to Publications; the prior revision tag v3.5.3 was removed.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedClinicalTrials.gov’s release/version label was updated from **v3.5.2** to **v3.5.3**, indicating a site revision rather than a change to the study record content.SummaryDifference0.0%

- Check33 days agoChange DetectedSite revision updated to v3.5.2; the previous revision v3.5.0 was removed.SummaryDifference0.0%

- Check55 days agoChange Detected- Study record dates updated with recent timestamps (2026-03-24, 2026-03-20, 2026-03) and removal of older timestamps (2026-03-17, 2026-02-24, 2026-02).SummaryDifference0.1%

- Check62 days agoChange DetectedThe study status changed to Completed. The EU CTIS number was added to the record and related study dates were updated.SummaryDifference0.3%

- Check69 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

Stay in the know with updates to DS-1062a in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DS-1062a in Lung Cancer Clinical Trial page.